## Related Work

**Related Papers**
1. **Title**: Medical Device Validation: X-In-The-Loop Framework (Grau et al. 2024)
   - **Authors**: Grau et al.
   - **Summary**: Systematic staged validation framework (Model-in-Loop → Software-in-Loop → Hardware-in-Loop) for medical devices with proven 60-80% efficiency gains in highly regulated markets through systematic gate validation.
   - **Year**: 2024

2. **Title**: AHA Advisory: AI Evaluation & Monitoring (Jain et al. 2025)
   - **Authors**: Jain et al.
   - **Summary**: Proposes 3-phase framework (predeployment, implementation, postdeployment) for healthcare AI with risk-proportionate evaluation, identifies resource constraints and need for pragmatic approaches.
   - **Year**: 2025

3. **Title**: Utility Metrics for Synthetic Health Data (El Emam et al. 2022)
   - **Authors**: El Emam et al.
   - **Summary**: Validated multivariate Hellinger distance as reliable metric to rank synthetic data generation methods across 30 health datasets, providing empirical evidence for automated utility evaluation.
   - **Year**: 2022

4. **Title**: Doctor-in-the-Loop Qualitative Evaluation (Silva et al. 2025)
   - **Authors**: Silva et al.
   - **Summary**: Methodology for efficient clinical expert evaluation of synthetic medical data through structured assessment protocols, demonstrating feasibility of expert sampling approaches.
   - **Year**: 2025

5. **Title**: SynthRAD2023 Grand Challenge (Thummerer et al. 2023)
   - **Authors**: Thummerer et al.
   - **Summary**: Multi-center dataset (540 brain + 540 pelvis CT/CBCT/MRI) across 3 centers with varying protocols, demonstrating feasibility of multi-institutional validation for synthetic medical data.
   - **Year**: 2023

6. **Title**: Continuous QA for Adaptive ML Systems (Grover et al. 2025)
   - **Authors**: Grover et al.
   - **Summary**: Continuous verification in ML systems through automated QA pipelines embedded in MLOps, demonstrating that real-time quality assurance reduces model failures and shortens feedback-to-repair cycles.
   - **Year**: 2025

7. **Title**: SMD_ScoreCard - Synthetic Medical Data Evaluation Library
   - **Authors**: Not specified
   - **Summary**: Python library for evaluating quality of synthetic medical data with automated metrics, providing open-source tool to reduce implementation burden for automated validation.
   - **Year**: Not specified

8. **Title**: synthEHRella - Synthetic EHR Benchmarking Package
   - **Authors**: Not specified
   - **Summary**: Benchmarking package for evaluating synthetic EHR data generation methods, providing standardized evaluation protocols.
   - **Year**: Not specified

9. **Title**: syntheval - Synthetic Data Quality Evaluation
   - **Authors**: Not specified
   - **Summary**: Software for evaluating quality of synthetic data versus real data, providing comparative quality metrics.
   - **Year**: Not specified

10. **Title**: Governance Framework for Synthetic Medical Data (Udechukwu 2025)
    - **Authors**: Udechukwu
    - **Summary**: Focuses on governance and data privacy aspects of synthetic medical data, providing complementary governance perspective to technical validation approaches.
    - **Year**: 2025

11. **Title**: Review Calling for Standards in Generative Medical AI (Fadul 2025)
    - **Authors**: Fadul
    - **Summary**: Identifies the gap in standardized validation frameworks for generative medical AI and calls for development of standards, but proposes no concrete solution.
    - **Year**: 2025

**Key Challenges**
1. **Lack of Standardized Clinical Validation Frameworks**: Existing frameworks propose structure but lack practical implementation pathways with concrete tool integration and economic incentives for adoption.

2. **Automated-to-Clinical Metric Correlation Gap**: Need to validate that automated technical metrics (FID, SSIM, Hellinger distance) correlate with clinical utility at correlation ≥0.7 to ensure automated filtering doesn't miss unsafe models.

3. **Cross-Domain Transfer Validity**: Systems Engineering X-in-the-Loop methodology validated for deterministic medical devices but not for stochastic generative AI systems - analogy validity requires empirical validation.

4. **Resource Constraints in Validation**: Current validation approaches require extensive clinical expert time (~100 hours per model), creating economic barriers to deployment particularly in resource-constrained healthcare settings.

5. **Regulatory Acceptance Uncertainty**: No official FDA endorsement yet for staged validation frameworks, creating risk that validated models may not achieve regulatory approval despite passing all validation stages.

6. **Multi-Center Validation Fragmentation**: Inconsistent validation methodologies across healthcare institutions, preventing standardized cross-institutional validation and creating deployment barriers.

7. **Privacy-Performance Trade-off in Federated Monitoring**: Federated learning for continuous performance monitoring must balance differential privacy requirements (<1% re-identification risk) against drift detection performance, with trade-off optimization not yet established.

8. **Threshold Optimization Requirements**: Optimal cutoff values for automated metrics (FID, SSIM, Hellinger distance, biomarker preservation) that maximize automated-to-clinical correlation while maintaining acceptable false positive/negative rates remain unvalidated.

9. **Sampling Coverage Efficiency**: Minimum sampling coverage required to achieve ≥95% validation accuracy using stratified sampling approaches remains empirically unvalidated (20-40% assumed but not proven).

10. **Integration Overhead Uncertainty**: Tool integration costs (SMD_ScoreCard, syntheval, synthEHRella) into unified automated pipeline may exceed efficiency gains if engineering overhead >50%.
